Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging

Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging

The SARS-CoV-2 pandemic has had a disastrous impact on global health. Although some vaccine candidates have been effective in combating SARS-CoV-2, logistical, economical, and sociological aspects still limit vaccine access globally. Recently, we reported on two room-temperature stable AAV-based COV...

Full description

Bibliographic Details
Main Authors: Bhatt, U. (Author), Chauhan, R. (Author), Diop, C. (Author), Estelien, R. (Author), Li, D. (Author), Maciorowski, D. (Author), Vandenberghe, L.H (Author), Zabaleta, N. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
AAV
adeno-associated virus
aged
Aged
aging
Aging
animal
animal model
Animals
Antibodies, Neutralizing
Antibodies, Viral
coronavirus spike glycoprotein
COVID-19
COVID-19 Vaccines
disease model
Disease Models, Animal
genetic vaccine
human
Humans
Mice
mouse
neutralizing antibody
obesity
Obesity
prevention and control
SARS-CoV-2
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
vaccine
Vaccines
virus antibody
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items